Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Biden administration selects 15 new medications up for price negotiations including weight loss drugs Ozempic and Wegovy.

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

WASHINGTON (AP) — Biden administration selects 15 new medications up for price negotiations including weight loss drugs Ozempic and Wegovy.

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, there are concerns about the accompanying loss of muscle tissue.

Weight loss drugs like Ozempic and Wegovy cost an average of $1,083 per month if you pay full price or $325 per ... Many health insurance plans don't cover the weight loss drug Zepbound because it's ...